<p>A. RCC cells (Caki-1 and 786-O) were treated with DMSO (Cont), GW6471 (GW) 25 µM, and/or 2-DG (5 mM) for 72 hours and cell viability assay was performed as described in Materials and Methods. B. RCC cells (Caki-1 and 786-O) were treated with DMSO (Cont), GW6471 (GW) 25 µM, low glucose media (Lo Glu), or GW6471 in low glucose for 72 hours and cell viability was assessed by an MTT assay as described in Materials and Methods. The data shown are representative of at least three repeats. **Synergistic effect compared to each treatment separately. Error bars indicate standard deviation.</p
<p>(A) Simultaneous treatment with 10 mmol/L NAC restored ROS to basal levels in HCC-LM<sub>3</sub> ...
Metabolic syndrome consists of insulin resistance, dyslipidaemia, obesity among other metabolic defe...
<p>(A) Viability graph of RCC4 cells treated with 10 µM or 20 µM CQ, 20 µM CCI-779 or combination of...
<p>RCC cells (Caki-1 and 786-O) were treated with DMSO, WY14,643 (WY), or GW6471 (GW) at the indicat...
<p>A. RCC cells (Caki-1 and 786-O) were treated with DMSO or GW6471 (GW) at the indicated doses for ...
<p>RCC cells (Caki-1 and 786-O) were treated with DMSO (Cont) or GW6471 (GW) 25 µM for 24 hours and ...
<p>(A) Treatment of MG63 cells with phloretin (100 µM), daunomycin (1 µM), 5-Fu (10 µM), etoposide 1...
<p>(A) Inhibitory effects of DHA combined with 2-Deoxy-D-glucose (2DG) on cell proliferation in A549...
<p><b>(A)</b> Western blot analysis of the expression level of PPARγ in PL45, PANC-1, MIA PaCa-2, Bx...
<p>The viability curves of B cells and PBMCs after four days of incubation with different concentrat...
<p>Caki-1 (<b>A</b>) and 786-O (<b>B</b>) cells were plated and treated with 2 µM Ku0063794, 300 nM ...
(A) Ph+ cells TOM-1 seeded with DMSO, dasatinib 50 nM, bortezomib 5 nM and the combination at day 0,...
<p>(A and B) A549 and PC-9 cells were cultured with DMEM free glucose medium with different concentr...
Lipid mediators have complex effects on the cell; one of the key transcriptional factors that modera...
<p>(A) MDA-MB-231 cells were treated with metformin and 600 μM 2-DG for 72 hours in low-glucose (1 g...
<p>(A) Simultaneous treatment with 10 mmol/L NAC restored ROS to basal levels in HCC-LM<sub>3</sub> ...
Metabolic syndrome consists of insulin resistance, dyslipidaemia, obesity among other metabolic defe...
<p>(A) Viability graph of RCC4 cells treated with 10 µM or 20 µM CQ, 20 µM CCI-779 or combination of...
<p>RCC cells (Caki-1 and 786-O) were treated with DMSO, WY14,643 (WY), or GW6471 (GW) at the indicat...
<p>A. RCC cells (Caki-1 and 786-O) were treated with DMSO or GW6471 (GW) at the indicated doses for ...
<p>RCC cells (Caki-1 and 786-O) were treated with DMSO (Cont) or GW6471 (GW) 25 µM for 24 hours and ...
<p>(A) Treatment of MG63 cells with phloretin (100 µM), daunomycin (1 µM), 5-Fu (10 µM), etoposide 1...
<p>(A) Inhibitory effects of DHA combined with 2-Deoxy-D-glucose (2DG) on cell proliferation in A549...
<p><b>(A)</b> Western blot analysis of the expression level of PPARγ in PL45, PANC-1, MIA PaCa-2, Bx...
<p>The viability curves of B cells and PBMCs after four days of incubation with different concentrat...
<p>Caki-1 (<b>A</b>) and 786-O (<b>B</b>) cells were plated and treated with 2 µM Ku0063794, 300 nM ...
(A) Ph+ cells TOM-1 seeded with DMSO, dasatinib 50 nM, bortezomib 5 nM and the combination at day 0,...
<p>(A and B) A549 and PC-9 cells were cultured with DMEM free glucose medium with different concentr...
Lipid mediators have complex effects on the cell; one of the key transcriptional factors that modera...
<p>(A) MDA-MB-231 cells were treated with metformin and 600 μM 2-DG for 72 hours in low-glucose (1 g...
<p>(A) Simultaneous treatment with 10 mmol/L NAC restored ROS to basal levels in HCC-LM<sub>3</sub> ...
Metabolic syndrome consists of insulin resistance, dyslipidaemia, obesity among other metabolic defe...
<p>(A) Viability graph of RCC4 cells treated with 10 µM or 20 µM CQ, 20 µM CCI-779 or combination of...